Clinical Trials Directory

Trials / Unknown

UnknownNCT04265495

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !?

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? a Prospective Randomized Controlled Comparative Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Al Baraka Fertility Hospital · Academic / Other
Sex
Female
Age
22 Years – 40 Years
Healthy volunteers
Accepted

Summary

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome of ICSI- antagonist cycles

Detailed description

a comparative study among dual trigger, urinary HCG and recombinant HCG regarding the outcome (oocyte quality, fertilization rate, implantation rate, clinical pregnancy rate as well as the incidence of OHSS) in ICSI- antagonist cycles

Conditions

Timeline

Start date
2020-02-09
Primary completion
2021-11-30
Completion
2021-12-01
First posted
2020-02-11
Last updated
2021-09-28

Locations

1 site across 1 country: Bahrain

Source: ClinicalTrials.gov record NCT04265495. Inclusion in this directory is not an endorsement.

Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? (NCT04265495) · Clinical Trials Directory